sq-11725 has been researched along with nitroarginine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balligand, JL; Dessy, C; Ghisdal, P; Havaux, X; Moniotte, S; Noirhomme, P | 1 |
1 other study(ies) available for sq-11725 and nitroarginine
| Article | Year |
|---|---|
Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization.
Topics: Adolescent; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Apamin; Arterioles; Bupranolol; Charybdotoxin; Child; Coronary Vessels; Endothelium, Vascular; Ethanolamines; Female; Humans; Isoproterenol; Male; Membrane Potentials; Microcirculation; Microscopy, Video; Middle Aged; Nadolol; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Potassium Channel Blockers; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; RNA, Messenger; Vasodilation | 2004 |